Young Diane C.

CIK 00016480102 companiesHAMPTON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001648010

Recent Transactions

28 trades

Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2025-06-05+72,000→ 72,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2024-06-13+72,000→ 72,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option
2024-06-11−15,000→ 0 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-06-11$2.71/sh+15,000→ 17,115 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-06-07$35.26/sh−45,000→ 2,115 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2023-06-15+80,000→ 80,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option
2022-08-17−19,000→ 48,400 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-17$10.38/sh+19,000→ 21,115 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-17$2.71/sh+45,000→ 47,115 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option
2022-08-17−45,000→ 15,000 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-17$37.30/sh−19,000→ 2,115 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2022-06-16+76,000→ 76,000 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-12$42.94/sh−4,600→ 2,115 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-12$10.38/sh+4,600→ 6,715 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2021-11-12−4,600→ 67,400 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2021-06-17+72,000→ 72,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2020-06-18+72,000→ 72,000 total
Purchase
Celldex Therapeutics, Inc.$CLDX
Common stock, par value $0.001 per share
2020-06-11$4.73/sh+2,115→ 2,115 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2019-07-08+60,000→ 60,000 total
Sale
Oncternal Therapeutics, Inc.
Common Stock
2018-07-16$14.70/sh−2,049→ 45,936 total
Sale
Oncternal Therapeutics, Inc.
Common Stock
2018-07-16$14.70/sh+2,049→ 45,936 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2018-07-13$14.92/sh−2,014→ 47,985 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2018-07-13$14.92/sh−2,014→ 47,985 total
Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2018-01-01+25,000→ 25,000 total
Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2017-02-28+50,000→ 50,000 total
Sale
Oncternal Therapeutics, Inc.
Common Stock
2016-10-28$7.70/sh−500→ 0 total
Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-01-01+150,000→ 150,000 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2015-07-13+500,000→ 500,000 total

Companies

Recent Filings

Address

C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220

HAMPTON, NJ, 08827

View on SEC.gov